PALO ALTO, Calif., May 23 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. (NYSE: VAR) has received FDA 510(k) clearance that permits the use of the company's high-energy, ultra-precise Trilogy™ linear accelerators on an expanded range of medical conditions. The clearance also marks the introduction of Varian's new Trilogy Tx™ Image-Guided Radiosurgery (IGRS) model designed specifically for surgeons.
Varian's Trilogy and Trilogy Tx machines now can be used for stereotactic radiosurgery as well as precision radiotherapy for lesions, tumors, and conditions anywhere in the body when radiation treatment is indicated.
"With this new clearance, physicians can begin to provide Trilogy Treatments™ for functional lesions like trigeminal neuralgia and other non-cancerous conditions," said Lester Boeh, vice president and general manager of Varian Surgical Sciences. "The prior FDA clearance for the Trilogy device was limited to benign and malignant cancers, and arteriovenous malformations.
"This expanded FDA clearance for the Trilogy and Trilogy Tx machines demonstrates our commitment to meeting the needs of image-guided radiosurgery," Boeh said. "Future enhancements to the Trilogy Tx device will focus on functionality that is important to the surgeon." A prototype of the new Trilogy Tx model was exhibited at the American Association of Neurological Surgeons (AANS) annual meeting last month in San Francisco.
For more information, visit the Varian Surgical Sciences website at http://www.varian.com/vss/.
ABOUT VARIAN MEDICAL SYSTEMS, INC.
Varian Medical Systems, Inc., of Palo Alto, California is the world's leading manufacturer of medical technology for treating cancer with radiotherapy and neurological conditions with radiosurgery. The company is also a premier supplier of X- ray tubes and flat-panel digital subsystems for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 3,600 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world. Additional information is available on the company's web site at http://www.varian.com/.
FORWARD LOOKING STATEMENTS
Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "will," "can," and "possible" constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.
FOR INFORMATION CONTACT: Spencer Sias 650-424-5782 firstname.lastname@example.org Meryl Ginsberg 650-424-6444 email@example.com
SOURCE: Varian Medical Systems, Inc.
Web site: http://www.varian.com/